These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24717015)

  • 1. The current relevance and use of prednisone in rheumatoid arthritis.
    Krasselt M; Baerwald C
    Expert Rev Clin Immunol; 2014 May; 10(5):557-71. PubMed ID: 24717015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fresh look at glucocorticoids how to use an old ally more effectively.
    Buttgereit F
    Bull NYU Hosp Jt Dis; 2012; 70 Suppl 1():26-9. PubMed ID: 23259655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids in the treatment of rheumatoid arthritis: still used after 65 years.
    Bijlsma JW; Jacobs JW
    Ann N Y Acad Sci; 2014 May; 1318():27-31. PubMed ID: 24641732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials documenting the efficacy of low-dose glucocorticoids in rheumatoid arthritis.
    Pincus T; Cutolo M
    Neuroimmunomodulation; 2015; 22(1-2):46-50. PubMed ID: 25227901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What explains the variation among rheumatologists in their use of prednisone and second line agents for the treatment of rheumatoid arthritis?
    Criswell LA; Henke CJ
    J Rheumatol; 1995 May; 22(5):829-35. PubMed ID: 8587068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of glucocorticoids in rheumatoid arthritis.
    Spies CM; Bijlsma JW; Burmester GR; Buttgereit F
    Curr Opin Pharmacol; 2010 Jun; 10(3):302-7. PubMed ID: 20202903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prednisone for rheumatoid arthritis: the detriment of the doubt].
    Boers M
    Ned Tijdschr Geneeskd; 2012; 155(32):A5069. PubMed ID: 22871244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial.
    Buttgereit F; Doering G; Schaeffler A; Witte S; Sierakowski S; Gromnica-Ihle E; Jeka S; Krueger K; Szechinski J; Alten R
    Lancet; 2008 Jan; 371(9608):205-14. PubMed ID: 18207016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists.
    Criswell LA; Such CL; Yelin EH
    J Rheumatol; 1997 Dec; 24(12):2283-90. PubMed ID: 9415629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intelligent use of systemic glucocorticoids in rheumatoid arthritis.
    Mercieca C; Kirwan JR
    Expert Rev Clin Immunol; 2014 Jan; 10(1):143-57. PubMed ID: 24308837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified release prednisone in patients with rheumatoid arthritis.
    Jacobs JW; Bijlsma JW
    Ann Rheum Dis; 2010 Jul; 69(7):1257-9. PubMed ID: 20525834
    [No Abstract]   [Full Text] [Related]  

  • 12. Old But Good: Modified-Release Prednisone in Rheumatoid Arthritis.
    Ursini F; Naty S; Bruno C; Grembiale RD
    Rev Recent Clin Trials; 2017; 12(2):124-128. PubMed ID: 28356031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronotherapy with modified-release prednisone in patients with rheumatoid arthritis.
    Alten R
    Expert Rev Clin Immunol; 2012 Feb; 8(2):123-33. PubMed ID: 22288450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early disease control by low-dose prednisone comedication may affect the quality of remission in patients with early rheumatoid arthritis.
    Todoerti M; Scirè CA; Boffini N; Bugatti S; Montecucco C; Caporali R
    Ann N Y Acad Sci; 2010 Apr; 1193():139-45. PubMed ID: 20398020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are glucocorticoids harmful to bone in early rheumatoid arthritis?
    Lems WF
    Ann N Y Acad Sci; 2014 May; 1318():50-4. PubMed ID: 24739059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis.
    Krasselt M; Baerwald C
    Drug Des Devel Ther; 2016; 10():1047-58. PubMed ID: 27022244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis.
    del Rincón I; Battafarano DF; Restrepo JF; Erikson JM; Escalante A
    Arthritis Rheumatol; 2014 Feb; 66(2):264-72. PubMed ID: 24504798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of low-dose prednisone in the management of rheumatoid arthritis.
    Lim SS; Conn DL
    Bull Rheum Dis; 2001; 50(12):1-4. PubMed ID: 12386945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation on Brazilian clinical practices in rheumatoid arthritis: the Brazilian rheumatoid arthritis clinical practices investigation--BRACTICE.
    Helfenstein M; Halpern AS; Bertolo MB
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 1):S1-10. PubMed ID: 21654277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
    Solomon DH; Katz JN; Jacobs JP; La Tourette AM; Coblyn J
    Arthritis Rheum; 2002 Dec; 46(12):3136-42. PubMed ID: 12483716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.